AKT1 and Alzheimer disease: When experiencing impaired insulin-related signaling pathways, insulin resistance and hyperinsulinemia, IDE, a degrading enzyme of insulin and Aβ, is considered as a bridge linking diabetes and CI and AD via the potential signaling pathways of PI3K/AKT/GSK3β, PPARγ and NFκB [59].